PMID: 7035298Jan 1, 1982Paper

Treatment of hepatic encephalopathy with metronidazole

Gut
M Y MorganD C Speller

Abstract

Neomycin, an antibiotic which is primarily active against the aerobic gut flora and hence reduces the endogenous production of ammonia, is a well-recognised form of treatment for acute or acute on chronic hepatic encephalopathy. This study suggests that metronidazole may be a useful alternative or even adjunctive treatment for such patients. Theoretical and practical justifications for the use of this drug are presented. The results of a week's prescription of each drug have been assessed by changes in clinical and biochemical criteria, including electroencephalograms and arterial ammonia sample. In the treatment of a series of 11 mildly or moderately, and seven severely affected, patients with histologically confirmed cirrhosis, metronidazole is shown to be as effective as neomycin.

References

Dec 17, 1977·Lancet·H C ThomasS Sherlock
Sep 1, 1979·The Journal of Antimicrobial Chemotherapy·Y ArabiM R Keighley
Mar 1, 1979·The Journal of Antimicrobial Chemotherapy·A B OnderdonkJ G Bartlett
Nov 1, 1979·The Journal of Antimicrobial Chemotherapy·H R InghamJ B Selkon
Aug 21, 1971·Lancet·C L BrownP Richards
Nov 9, 1968·Lancet·A E ReadG J Brown
Aug 1, 1973·The American Journal of the Medical Sciences·J M Fessel, H O Conn
Jul 1, 1972·The Journal of Infectious Diseases·L J Nastro, S M Finegold
Sep 1, 1970·Annals of Internal Medicine·D P Berk, T Chalmers
May 1, 1980·Journal of Medical Microbiology·A J Vince, S M Burridge
Feb 1, 1955·The Journal of Clinical Investigation·L P WHITES SHERLOCK
Oct 1, 1957·Neurology·A FOIS, C M ROSENBERG
Dec 21, 1957·Lancet·A M DAWSONS SHERLOCK
Jan 1, 1959·A.M.A. Archives of Internal Medicine·W W FALOON, C J FISHER
Oct 1, 1960·The American Journal of Medicine·H O CONN
May 2, 1964·British Medical Journal·A H DAVIESS SQUIRES

❮ Previous
Next ❯

Citations

Feb 8, 2013·Metabolic Brain Disease·Kavish R Patidar, Jasmohan S Bajaj
Nov 7, 2001·Current Treatment Options in Gastroenterology·Srinivasan Dasarathy, Kevin D. Mullen
Nov 4, 2006·Current Treatment Options in Gastroenterology·Nader Dbouk, Brendan M McGuire
Dec 11, 2002·Journal of Gastroenterology and Hepatology·Gerald Kircheis, Dieter Häussinger
Aug 14, 1997·The New England Journal of Medicine·S M Riordan, R Williams
Jan 30, 2010·Transplantation·Lewis W Teperman, Vincent P Peyregne
Feb 4, 1984·British Medical Journal·T K Daneshmend, C J Roberts
Mar 31, 1984·British Medical Journal·G FarrellJ Baird-Lambert
Apr 28, 2005·Chemotherapy·Maria Luisa ZeneroliMario Baraldi
Feb 1, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Giannakis T TorisStamatios E Theocharis
Aug 27, 2009·Therapeutics and Clinical Risk Management·Mohamad Rasm Al Sibae, Brendan M McGuire
Jun 4, 2010·Drugs·Paula V PhongsamranAngela Rosenblatt
Apr 2, 2011·Journal of the American Veterinary Medical Association·Scott L Owens, Nolie K Parnell
Mar 1, 2012·World Journal of Gastroenterology : WJG·Karim M EltawilMichele Molinari
Mar 5, 2011·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Praveen Sharma, Barjesh C Sharma
Nov 8, 2012·International Journal of Hepatology·Z Poh, P E J Chang
Jan 20, 2004·Radiographics : a Review Publication of the Radiological Society of North America, Inc·David C MadoffRichard R Saxon
Sep 9, 1995·Lancet·J C QueroS W Schalm
Dec 11, 2013·International Journal of Hepatology·Lewis W Teperman
Oct 11, 2014·Inflammopharmacology·Christopher SheasgreenAmeen Patel
Apr 1, 1985·Scandinavian Journal of Gastroenterology·B A Hansen, H Vilstrup
Jan 15, 2014·Mayo Clinic Proceedings·Michael D LeiseW Ray Kim
May 17, 2011·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·A García-SabinaR Martínez-Pacheco
Aug 10, 2010·Critical Care Nursing Clinics of North America·Keith J FosterCharles J Turck
Jul 7, 2009·The Medical Clinics of North America·Vinay Sundaram, Obaid S Shaikh
Feb 14, 2007·Alimentary Pharmacology & Therapeutics·N M Bass
Mar 12, 2010·Journal of Clinical Pharmacology·Michelle M BottenbergRavinder Kumar
Jul 22, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hendrik VilstrupPhilip Wong
May 1, 1997·Clinics in Liver Disease·S Schenker, M K Bay
Jul 13, 2014·Journal of Hepatology·UNKNOWN American Association for the Study of Liver Diseases, UNKNOWN European Association for the Study of the Liver
Jun 28, 2011·Journal of Hepatology·Bruno OzannePhilippe Jouvet
Mar 1, 1995·The Veterinary Clinics of North America. Small Animal Practice·J Taboada, D S Dimski
Mar 1, 1995·The Veterinary Clinics of North America. Small Animal Practice·D Hughes, L G King
Jun 25, 2016·Critical Care Clinics·Prem A Kandiah, Gagan Kumar
Dec 21, 2004·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kazuhiro Katayama
Jan 1, 1987·Scandinavian Journal of Gastroenterology·S LoftP B Andreasen
May 24, 2017·Gastroenterology Report·Peter Ferenci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.